MTX and Steroid for III-IV aGVHD Treatment

NCT04958538 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft Versus Host Disease

Interventions

DRUG: Methotrexate

Sponsor

Peking University People's Hospital